RASSF1 Antibody (Center) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9NS23 |
---|---|
Clone Names | 90415014 |
Gene ID | 11186 |
---|---|
Other Names | Ras association domain-containing protein 1, RASSF1 {ECO:0000312|EMBL:AAF351282} |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | RASSF1 {ECO:0000312|EMBL:AAF35128.2} |
---|---|
Function | Potential tumor suppressor. Required for death receptor- dependent apoptosis. Mediates activation of STK3/MST2 and STK4/MST1 during Fas-induced apoptosis by preventing their dephosphorylation. When associated with MOAP1, promotes BAX conformational change and translocation to mitochondrial membranes in response to TNF and TNFSF10 stimulation. Isoform A interacts with CDC20, an activator of the anaphase-promoting complex, APC, resulting in the inhibition of APC activity and mitotic progression. Inhibits proliferation by negatively regulating cell cycle progression at the level of G1/S-phase transition by regulating accumulation of cyclin D1 protein. Isoform C has been shown not to perform these roles, no function has been identified for this isoform. Isoform A disrupts interactions among MDM2, DAXX and USP7, thus contributing to the efficient activation of TP53 by promoting MDM2 self-ubiquitination in cell-cycle checkpoint control in response to DNA damage. |
Cellular Location | [Isoform A]: Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, spindle. Cytoplasm, cytoskeleton, spindle pole. Nucleus Note=Localizes to cytoplasmic microtubules during interphase, to bipolar centrosomes associated with microtubules during prophase, to spindle fibers and spindle poles at metaphase and anaphase, to the midzone during early telophase, and to the midbody in late telophase in cells. Colocalizes with MDM2 in the nucleus |
Tissue Location | Isoform A and isoform C are ubiquitously expressed in all tissues tested, however isoform A is absent in many corresponding cancer cell lines. Isoform B is mainly expressed in hematopoietic cells. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a protein similar to the RAS effectorproteins. Loss or altered expression of this gene has beenassociated with the pathogenesis of a variety of cancers, whichsuggests the tumor suppressor function of this gene. Theinactivation of this gene was found to be correlated with thehypermethylation of its CpG-island promoter region. The encodedprotein was found to interact with DNA repair protein XPA. Theprotein was also shown to inhibit the accumulation of cyclin D1,and thus induce cell cycle arrest. Seven alternatively splicedtranscript variants of this gene encoding distinct isoforms havebeen reported.
References
El-Kalla, M., et al. Oncogene 29(42):5729-5740(2010)Vardi, A., et al. In Vivo 24(4):393-400(2010)Kim, J.H., et al. Virchows Arch. 457(1):35-42(2010)Ahmed, I.A., et al. Cancer Genet. Cytogenet. 199(2):96-100(2010)Zhang, H., et al. Zhongguo Fei Ai Za Zhi 13(4):311-316(2010)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.